Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Tiamiprine

    • Product Name Tiamiprine
    • Alias Duazide
    • Einecs 250-382-5
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    655321

    name Tiamiprine
    chemical_formula C13H15N3S
    molecular_weight 245.35 g/mol
    drug_class Immunosuppressant
    CAS_number 4580-46-7
    ATC_code None
    appearance White to off-white crystalline powder
    route_of_administration Oral
    mechanism_of_action Thiopurine immunosuppressant
    synonyms Thiopurinil, Thiamiprine
    pubchem_cid 17157

    As an accredited Tiamiprine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Tiamiprine is supplied in a white, sealed 100-gram HDPE bottle with a tamper-evident cap and clear hazard labeling.
    Shipping Tiamiprine is shipped in compliance with applicable chemical transport regulations, typically in secure, sealed containers to prevent contamination or leakage. Packaging ensures product integrity and protection from light, moisture, and mechanical stress. All shipments include appropriate labeling, documentation, and safety information required for safe handling and delivery.
    Storage Tiamiprine should be stored in a tightly closed container, protected from light and moisture, at room temperature (15–25°C or 59–77°F). Keep it away from incompatible materials, such as strong oxidizers. Store in a well-ventilated, dry area designed for chemical storage. Ensure access is limited to trained personnel and follow all safety regulations for handling hazardous substances.
    Application of Tiamiprine

    Applications of Tiamiprine in Industrial Manufacturing

    As a specialized manufacturer with years of process experience, we address the requirements of regulated, process-driven industries that depend on the distinct performance attributes of Tiamiprine. Our production quality ensures every order meets industry-specific expectations for purity and consistency. The following detailed application scenarios present how downstream partners in different sectors integrate Tiamiprine into their established manufacturing workflows to realize final goods that pass rigorous performance, safety, and compliance benchmarks.

    1. Veterinary Pharmaceutical Formulations

    Global veterinary drug manufacturers use Tiamiprine as an active pharmaceutical ingredient (API) in several antimicrobial preparations targeting livestock and companion animals. Within integrated GMP-certified facilities, downstream partners process it via granulation or suspension techniques, adjusting the formula to species-specific pharmacokinetic profiles. Formulators determine incorporation levels based on clinical efficacy studies and local legislation, balancing therapeutic outcomes with residue management in edible tissues.

    Industry compliance standards

    • Good Manufacturing Practice (GMP) for Veterinary Drugs (e.g., EU GMP Vol. 4, VICH GL guidelines)
    • Pharmacopoeial monographs (USP, Ph. Eur. as applicable)
    • Veterinary Drug Administration Law (China), FDA 21 CFR 514 (USA), EMA/CVMP guidelines (EU)
    • Antimicrobial Residue Control Programs (Codex Alimentarius MRLs, Japan MRL, FDA GFI #152)

    Typical usage ratio

    • Standard inclusion: 1%–10% API by weight for premix and oral solution formulations (precise dose set by species, target infection, and route of administration)
    • Lower inclusion (<1%) for combination formulations or adjunctive use; formulators recalculate based on clinical data and MRL compliance for food-producing species

    Downstream process integration

    • API dispensing and sieving, followed by direct charging into pre-mixed carriers (corncob, wheat bran) or solubilization for liquid/suspension forms
    • Blending within closed mixers under validated conditions, with subsequent milling or suspension homogenization before primary fill
    • Final step includes in-process testing for content uniformity, stability, and API identity

    Final product types

    • Veterinary premix powders for feed
    • Oral liquid and suspension pharmaceuticals
    • Medicated boluses/tablets
    • Top-dress feed supplements for swine, poultry, cattle

    2. Medicated Feed Additive Production

    Premix and compound feed manufacturers utilize Tiamiprine to produce medicated feeds for preventive treatment of bacterial infections in farm animals, following feed safety statutes and industry guidelines. The ingredient enters feedblending lines equipped to control cross-contamination and traceability, with process adjustments based on species, age group, and feed formulation. This application demands stringent batch documentation and compliance with authorized drug usage levels to avoid off-label exposure.

    Industry compliance standards

    • Feed Additive Directive 70/524/EEC (EU) and subsequent EU Regulation (EC) No 1831/2003
    • FDA Center for Veterinary Medicine (CVM) regulations for medicated feeds (21 CFR 558)
    • HACCP-based Feed Safety Management (ISO 22000, FAMI-QS)
    • Maximum Residue Levels and approved withdrawal periods (Codex, FDA, local Ministry of Agriculture)

    Typical usage ratio

    • Authorized inclusion: 20–100 mg/kg of complete feed, adjusted by country-specific approvals and target animal (e.g., lower levels in starter feeds for piglets)
    • Manufacturers dilute with carrier materials to achieve low uniform final concentrations; premix levels before dilution: 0.5%–2%

    Downstream process integration

    • Weighing and pre-blending with inert carriers (such as calcium carbonate or soybean meal) to ensure even API distribution
    • Post-blending into compound feed using paddle or ribbon mixers
    • Quality control analysis (HPLC) performed on final feed batch to verify legal compliance

    Final product types

    • Complete and complementary medicated feeds
    • Starter and grower rations for livestock production
    • Feed concentrates for on-farm blending

    3. Livestock Drinking Water Medication Systems

    Integrated animal production businesses and commercial water medication service providers dissolve Tiamiprine in proportioned liquid dosing systems to deliver disease-control agents via automated drinkers. This scenario requires rapid dissolution and homogeneity to ensure consistent delivery throughout the livestock facility. Our manufacturing controls particle size distribution for reliable dispersion and minimizes interaction with storage tank linings and piping.

    Industry compliance standards

    • National Drug Registration for Drinking Water Medications (e.g., China Ministry of Agriculture, VMD UK Pt 1/2)
    • GMP for liquid medicinals (EU GMP Annex 1, US cGMP 21 CFR 211 as applicable)
    • Local water additive approval protocols and animal welfare guidelines
    • Residue and withdrawal time control, referencing Codex and regional MRLs

    Typical usage ratio

    • Water soluble formulation: 0.1–0.5 g/L of drinking water; precise use set by veterinarian based on disease condition, system capacity, and animal intake
    • Concentrated stock solutions may use 2–5% w/v, metered by dosing pumps

    Downstream process integration

    • Product dissolved in water tanks or automated stock solution containers fitted with stirrers
    • Dosage regulated via peristaltic pump into primary drinking water pipelines
    • Producers monitor solution stability and flow rate using in-line sensors

    Final product types

    • Ready-to-use medicated drinking water additives
    • Concentrated soluble powders for veterinary hospital or on-farm application
    • Bulk liquid premixes for intensive livestock operations

    4. Non-Sterile Veterinary Injectable Preparations

    Sterile compounding units in the animal health sector incorporate Tiamiprine in injectable suspension or emulsion forms intended for parenteral treatment regimes. This application demands careful control of raw material handling, particle fineness, and solubility profile to enable accurate syringe dosing, especially when used in multi-dose vials. Integration involves validated sterilization methods and strict batch-release testing for both actives and excipients.

    Industry compliance standards

    • Global GMP for Veterinary Injectables (21 CFR 211, EudraLex Vol. 4 Part II, China Veterinary Drug GMP)
    • Sterility assurance standard (USP <71>, Ph. Eur. 2.6.1)
    • Specification requirements: content, identity, particulate matter (USP, VICH Q6A/B guidelines)
    • Veterinary pharmacopoeial standards (Ph. Eur., British Veterinary Pharmacopoeia, Japanese Pharmacopoeia if marketed regionally)

    Typical usage ratio

    • Formulation: Typically 5%–20% API by weight of injectable suspension (depends on species, infection type, and injection protocol)
    • Multidose vial concentrations adjusted for species and intended dosing frequency

    Downstream process integration

    • Dispensing and micronization of API in HEPA-filtered suites
    • API dispersed in sterile vehicles (oil or aqueous base) using high-shear mixers
    • Terminal sterilization or aseptic fill-and-finish with in-process sampling for microbial checkpoints

    Final product types

    • Sterile injectable suspensions for cattle, swine, and small animals
    • Multi-dose veterinary vials with prescribable labeling
    • Single-use ampoules for field veterinary practitioners
    Free Quote

    Competitive Tiamiprine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Tiamiprine: Supporting Fields and Factories with Reliable Chemical Solutions

    Direct from the Plant: Tiamiprine by the People Who Make It

    Every batch of Tiamiprine comes straight off our line, not through a relabeler or warehouse. We invest in strict process controls and best-in-class purification to keep the quality of each kilogram as consistent as the last. Years in the chemical industry taught us that any shortcut in production—not just in raw materials, but in every stage—can cost clients wasted batches, plant downtime, and extra headaches. That is not how you keep a customer, and it’s not how you build a reputation steady enough to help shape the growth of multiple industries.

    Tiamiprine is an important compound for our clients in healthcare, agrochemicals, pharma intermediates, and specialty chemistry. Our formulation team has worked through hundreds of pilot runs to land on a standard product line: pure Tiamiprine, produced at scale, in a fine crystalline form. The compound’s chemical properties grew out of work with thioether-bridged pyrimidines, aiming for highly selective intermediate performance. What came out was a molecule with a stable shelf life, easy handling properties, and predictable performance. These features matter most during scale-up, registration, and transfer to large reactors.

    Product Model and Specifications: Details Matter Most

    The main model from our plant comes as Tiamiprine BP-627, crystalline solid, average particle size between 40 and 60 mesh, purity 99.7% by HPLC, water content typically below 0.3%. There is no ambiguity about what goes in the bag. We use automated blending and fractionation before final packing; each lot logs real-time analytical results to our central lab database. No two factories have identical needs, so we tune drying and sieving conditions for a consistent texture. No customer gets couriered a surprise—every drum already passed through UV, NMR, and mass spectrometry checks in-house.

    Customers often ask what makes one batch of Tiamiprine differ from another source. It’s not just an assay figure. Trace metals, solvent residues, and the presence of out-of-spec fragments all influence downstream impurity profiles. Our engineers use in-line FTIR monitoring to watch for trace contaminants during synthesis. The only way to guarantee purity reproducibly is to control the process from start to finish—not just buy and repackage what a larger company sends you.

    Packaging is usually in 25 kg fiber drums with double polyliner, but for specialized needs—especially small molecule research or clinical runs—5 kg and 1 kg containers run down a segregated line, avoiding cross-contact with anything else we make. We keep moisture below 0.3% not just for a nice looking spec sheet, but because our customers in electronics and API finishing see dramatic swings in reactivity from even minor water uptake. Routine audits by our regulars have reaffirmed the same thing: the tighter the spec, the fewer problems in their own plants.

    Actual Use Cases and Practical Benefits

    The market for Tiamiprine spread quickly once it became known that our process could keep up with tough regulatory regimes. Our active partners run Tiamiprine through to advanced intermediates used in disease control, both in pharmaceutical and pesticide applications. It serves as a core building block for thiazole-based actives. Chemical reliability in the hands of our partners means no batch loss, fewer uncontrolled impurities during late-stage reactions, and less risk of batch rejection during QA.

    Pharmaceutical companies rely on Tiamiprine for more than its purity. The compound’s melt profile remains sharply defined, holding its stability up to 140°C with zero decomposition noted in repeat DSC runs. We do not just trust the certificate of analysis: we pilot every raw material lot through multi-kilo reactions on our own floor and track chromatography for each major and minor peak. New customers come on board after reading third-party stability results. Regulars stay because recalls and deviations are rare to nonexistent.

    Agrochemical formulators point to something else. Tiamiprine blends easily with standard formulation tools, meaning no clogging at the feeder head and no new headaches during extrusion. In practice, that means lower downtime per shift, fewer filter blockages, less wasted solvent, and overall leaner operating costs in bulk processing. The powder resists cake formation, so not much time gets lost between refills. We have heard from tollers that downtime hits hardest when a drum of raw material shows up full of lumps or can’t pour smoothly. This was where most cost overruns hit before.

    In the compliance-heavy industries of Europe and North America, Tiamiprine’s consistent analytical profile has been critical. End users need supply chain documentation to clear audits on origin, specifications, traceability, and batch tracking. We keep year-by-year logs, making inspection straightforward. Any company that has failed an EU audit over undocumented synthetic steps knows the pain. For developing region buyers, documentation and analytical support give them a leg up competing against better-resourced rivals.

    Tiamiprine vs Other Chemical Intermediates: Experience from the Production Floor

    Tiamiprine entered a competitive market long dominated by legacy pyrimidine intermediates—most famously, thiamine-derived chlorides and methylpyrimidinyl sulfides. We went head-to-head with established products, but ended up seeing the customer base shift when they ran into bottlenecks with old intermediates. One common issue with older products has been batch-to-batch variability, especially around trace side products. A discrepancy between nominal purity and real-world reaction behavior shows up as yield drops or fails final impurity screening at the end of a long and expensive process. Our clients have switched to Tiamiprine after chasing down long chains of elusive impurities from alternate sources.

    Another repeated headache with traditionals: problem solubility and high caking tendencies. In reactors, that translates into uneven dosing, stuck pumps, or long mixing cycles. We engineered Tiamiprine for predictable behavior, focusing on how it handles during both large-volume and microgram additions. Our vacuum drying and sieving steps dial in pourability and minimal dust. This may sound technical, but anyone who has wrangled a blocked feed line or gotten covered in a cloud of fines understands the cost of ignoring these variables.

    Environmental compliance requires deep knowledge of waste profiles. Many pyrimidine intermediates, especially older grades, release sulfurous vapors or chlorides during handling. That impacts worker safety, permit compliance, and the choice of factory vent scrubbers. Tiamiprine gives off negligible volatile emissions under normal conditions, making it easier to clear health, safety, and air compliance checks. By running our own environmental impact studies—third-party verified—we flagged issues with a couple of upstream reagents and switched to less hazardous alternatives in manufacturing.

    Global buyers came to us at first for price stability, but many stick with us because of fewer surprise costs downstream. Factory managers know all too well that a few percentage points saved on raw material price evaporate quickly once scale-up, licensing, or rejection fees hit. Consistency translates into predictability once Tiamiprine enters their workflow. Old intermediates sometimes require more cleaning steps, higher volumes of solvent, or specialty waste disposal. With Tiamiprine, those steps drop out, and more product leaves the plant as finished goods, not as losses or hazardous waste.

    Production Know-How: Quality Pulls Ahead of Quantity

    In the chemical industry, the least expensive input rarely tells the whole story. Out on our plant floor, old equipment updates, new reactor controls, and regular investments in training have cut our incident rates. Skilled techs run every stage of Tiamiprine synthesis, backed by a deep understanding of not just ‘how,’ but ‘why’ each critical parameter matters. Reaction time, solvent grade, temperature steps, and workup procedures all combine. Every change to equipment or process runs through validation under Good Manufacturing Practice (GMP) and ISO guidelines, not lip service.

    It only takes one missed impurity run, one leaky drum, or one uphill fight with a shipment delay to wipe out slim margins. Making Tiamiprine with tight controls reduces those risks. Quality means fewer product holds, less time scrambling for emergency replacements, and a steadier relationship with inspection agencies. Our team shares responsibility for every batch sent out—every signature on our release documents ties back to a face on our production line.

    Plant experience also means knowing which changes actually improve the product without introducing new issues. For instance, shifting from vacuum strip-dryers to low-temp nitrogen blanketing not only dropped residual solvent levels but also improved workers’ safety. Instead of counting on luck during scale-up, we trial new techniques in-house and keep a record of what worked and what didn’t. If a problem shows up in the finished product, we have the process records to trace root causes and prevent a repeat.

    Being the manufacturer means we deal with feedback directly. End users call us with questions about flow properties, reactivity, and onsite logistics. Over years, their feedback shaped dozens of tweaks to the Tiamiprine process. Bottle-necked lines, slow product dissolution, unclear labeling—these challenges help us improve the next batch. The dialogue is direct, not filtered through middlemen. If something needs fixing, there’s no passing the buck.

    Industry Standards, Audits, and Earning Trust

    In regulatory conversations, knowledge has to run as deep as the barrels. Inspectors and audit teams challenge process flows down to sample logs. Our plant keeps full logs for each Tiamiprine batch, from raw feedstock testing to final product QC. Regular third-party audits under international and local regulations keep us competitive with any global supplier. Buyers know the difference between a supplier that files basic paperwork and one that can pull analytical histories for years back.

    We saw firsthand that organizations get burned chasing the cheapest quote, only to face rejected lots, missed compliance steps, or mystery impurity spikes. Our own best clients came back to us after a bad run elsewhere, realizing the value isn’t just chemistry but also the people who manage risk, documentation, and follow-up. These relationships last through market swings and regulatory shifts—it’s the company behind the drum that matters as much as the product inside.

    Our internal compliance team works alongside production, not as an afterthought. From REACH registration to customs clearance, every step is covered. Tiamiprine batches include traceability codes and direct shipment tracking. This may seem simple, but it is the difference between an easy audit and a months-long standstill. Documentation closes gaps that have cost others millions in lost opportunity.

    Tiamiprine: Innovation at Scale

    While other suppliers rely on legacy products, we push Tiamiprine into new spaces. For example, our collaborations led to pilot launches for next-generation crop protection agents using Tiamiprine as a key step. Pharma researchers trust us to deliver lots with the same impurity fingerprints every time, letting them file regulatory paperwork and run stability trials with confidence. Clients get continuity—not just from paperwork, but from the same engineering and synthesis approaches batch after batch.

    Feedback about packaging, shipment, and documentation reach us quickly, and we act on them. When customs flagged a drum for unclear labeling, we overhauled our code system and now supply dual-language instructions by default. When a long-standing partner requested alternate batch sizes for easier inventory handling, we set up a new mini-pack line just for them. Real problems—solved by the factory, not left for users to patch up on their own.

    Market conditions change each quarter, but trust lasts. We see the same companies returning, not because our prices never change, but because their lines keep running with our Tiamiprine. Stability, performance, and responsiveness win more orders than sales pitches or deep discounts. Our investment in scale means no rushing through critical synthesis steps during tight demand periods. We produce to order, stock for strategic clients, and ship with full batch records.

    Challenges and Solutions: Navigating Tough Markets

    Market demand never stays still. Prices in the raw material market jumped during pandemic years, and shipping delays hit almost every sector. We weathered these storms through long-term supply agreements, alternate vendor development, and tight controls on stock. Being the actual manufacturer, not a reseller, gave us better flexibility. If freight got tied up at port, we shifted shipping partners. If a key solvent price jumped, we absorbed the cost when possible and informed customers early about unavoidable adjustments.

    Environmental policy requirements keep tightening. We pre-empt incoming changes by tracking government announcements and industry associations, so our downstream users never get surprised by new restrictions. Each time there’s a call for lower emissions or lower solvent residues, we invest in new pretreatment and recycling equipment. Our plant upgrades focus less on buzzwords and more on what regulators, auditors, and practical operators actually inspect. Our emission controls, waste reduction strategies, and onsite safety drills show up in every inspection record.

    Supply chain shocks hit the whole industry. We responded by building redundancy into our own vendor network, qualifying multiple sources for every major input, and working to own as much of the process as possible. The point is not just security, but independence. If an input dries up or a distributor runs out, we know our process inside out and can adapt formulations to keep supply lines open. Rapid process adjustments are only possible for a manufacturer with both the technical depth and the authority to change specifications and keep everything documented.

    What to Expect Working with Our Tiamiprine

    Long-term partnerships succeed on clear terms and predictability. We offer every new buyer technical documentation, hands-on support, and transparent pricing, drawing on feedback from teams using Tiamiprine in everything from R&D to large-scale manufacturing. Unlike a third-party dealer, our support teams connect directly to the plant. Advice comes from technical operators, not a help desk reading scripts. If there’s an issue with a drum, the person answering already knows the process details and can help trace root causes or recommend adjustments in application.

    Clients see the whole Tiamiprine supply chain, from process chemistry to finished goods. We walk new customers through validation and technical onboarding, and maintain support in the field. Old-school service—no automated bots or layers of redirection, but people who live with the product every day. Successes get shared, and challenges shape our ongoing improvements. This kind of relationship stands out against the backdrop of commodity trading, where actual manufacturing expertise is rare.

    Tiamiprine’s value runs deeper than the numbers on a certificate of analysis. Direct engagement and process control lead to better batches, fewer supply chain headaches, and lasting confidence from partners with their own demanding production needs. The reality of chemical manufacturing doesn’t leave room for shortcuts. We keep refining every step—from raw material selection to final shipment—because every ton of Tiamiprine in the field or on the production line represents not just a product, but the reputation and experience of our whole company.